Crinetics Pharmaceuticals, Inc. — Form 8-K
Filed August 19, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Crinetics Pharmaceuticals filed an 8-K on 2026-08-19 reporting under Item 8.01 (Other Events). The filing document itself contains no substantive disclosure of the event's nature, dollar amounts, counterparties, dates, or business impact—only metadata, XBRL taxonomy extensions, and filing administration details are provided in the text supplied.
Why this rating
No material event details disclosed; 8-K text unavailable; routine administrative SEC filing with no quantified business impact.
Extracted items
See more from August 19, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.